Jeg3 human choriocarcinoma-induced immunosuppression: Downregulation of interleukin-2, interleukin-2 receptor α-chain, and its Jak/Stat signaling pathway

American Journal of Reproductive Immunology

Volumn 41, Issue 1, 1999, Pages 61-69

  Kilic, M ^a   Flossmann, E ^a   Flossmann, O ^a   Vogelsang, H ^a   Junker, U ^a   Chaouat, G ^b   Markert, Udo R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Choriocarcinoma; Interleukin 2; Interleukin 2 receptor; Jak; Lymphocytes; Placenta; Stat

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; IONOMYCIN; MONENSIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; DNA BINDING PROTEIN; PROTEIN TYROSINE KINASE; TRANSACTIVATOR PROTEIN;

CANCER CELL CULTURE; CHORIOCARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOBLOTTING; MALE; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ADULT; ARTICLE; BIOSYNTHESIS; CELL CULTURE; DOWN REGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; PHYSIOLOGY; PLACENTA; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CHORIOCARCINOMA; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2; LYMPHOCYTES; MALE; PLACENTA; PROTEIN-TYROSINE KINASES; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0032586950     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1999.tb00076.x     Document Type: Conference Paper

References (30)

1. Wolf RL, Ilekis J, Benveniste R: Characterization of an immune suppressor from transformed human trophoblastic Jeg-3 cells. Cell Immunol 1983; 78:356-367.
2. Canepa S: Propriétés immunosuppressives de surnageants de choriocarcinomes humains. DERBH, Université Paris 7, Paris, 1985.
3. Bustany P: Effets immunorégulateurs et suppresseurs inducteurs de surnageants de culture du choriocarcinome JAR. DEA, Université Paris 7, Paris, 1987.
4. Heine O: Habilitationsschrift. Universität Giessen, 1993.
5. Krishnan L, Menu E, Chaouat G, Talwar GP, Raghupathy R: In vitro and in vivo immunosuppressive effects of supernatants from human choriocarcinoma cell lines. Cell Immunol 1991; 138:313-325.
6. Krishnan L, Chaouat G, Kinsky R, Talwar GP, Raghupathy R: Suppression of local and systemic GVHR by supernatant from human choriocarcinoma cell lines. Cell Immunol 1993; 150:376-381.
7. Krishnan L, Sad S, Raghupathy R: Characterization of an immunosuppressive factor secreted by a human trophoblast-derived choriocarcinoma cell line. Cell Immunol 1995; 162:295-308.
8. Markert UR, Chaouat G: Preliminary characterization of an immunosuppressive inducer factor secreted by the Jeg-3 choriocarcinoma cell line: in vitro and in vivo studies. Am J Reprod Immunol 1997; 38:327-339.
9. Djian V, Menu E, Thibault G, Ropert S, Chaouat G: Immunoactive products of placenta. V: Immunoregulatory properties of a low molecular weight compound obtained from human placental cultures. Am J Reprod Immunol 1996; 36:11-24.
10. Darnell JE Jr, Kerr IM, Stark GM: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264:1415-1421.
11. Schindler C, Darnell JE Jr: Transcriptional responses to polypeptide ligands: the JAK/STAT pathway. Annu Rev Biochem 1995; 64:621-651.
12. Nakamura Y, Russell SM, Mess SA, Friedmann M, Erdos M, Francois C, Jacques Y, Adelstein S, Leonard WJ: Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature 1994; 369:330-333.
13. Nelson BH, Lord JD, Greenberg PD: Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation. Nature 1994; 369:333-336.
14. Watling D, Guschin D, Muller M, Silvennoinen O, Witthuhn BA, Quelle FW, Rogers NC, Schindler C, Stark GR, Ihle JN, Kerr IM: Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 1993; 366:166-170.
15. Müller M, Briscoe J, Laxton C, Guschin D, Ziemiecki A, Silvennoinen O, Harpur AG, Barbieri G, Witthuhn BA, Schindler C, Pellegrini S, Wilks AF, Ihle JN, Stark GR, Kerr IM: The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 1993; 366:129-135.
16. Horvath CM, Darnell JE Jr: The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr Opin Cell Biol 1997; 9:233-239.
17. Leonard WJ, O'Shea JJ: Jaks and STATs: biological implications. Annu Rev Immunol 1998; 16:293-322.
18. Martal J, Chene N, Camous S, Huynh L, Lantier F, Hermier P, L'Haridon R, Charpigny G, Charlier M, Chaouat G: Recent developments and potentialities for reducing embryo mortality in ruminants: the role of IFN-tau and other cytokines in early pregnancy. Reprod Fertil Dev 1997; 9:355-380.
19. King A, Loke YW: Human trophoblast and JEG choriocarcinoma cells are sensitive to lysis by IL-2-stimulated decidual NK cells. Cell Immunol 1990; 129:435-448.
20. Ferry BL, Sargent IL, Starkey PM, Redman CW: Cytotoxic activity against trophoblast and choriocarcinoma cells of large granular lymphocytes from human early pregnancy decidua. Cell Immunol 1991; 132:140-149.
21. Matsuzaki N, Okada T, Kameda T, Negoro T, Saji F, Tanizawa O: Analysis of site of action of a choriocarcinoma-derived immunoregulatory factor on IL-2 - mediated T cell responses. J Reprod Immunol 1989; 15:181-194.
22. Matsuzaki N, Saji F, Okada T, Sawai K, Kameda T, Tanizawa O: Analysis of immunoregulatory activity of a choriocarcinoma-derived factor: specific suppression of proliferative process of cell-mediated immune responses including LAK cell generation. J Reprod Immunol 1991; 19:101-114.
23. Jarvis JN, Zhao L, Moore HT, Long PM, Vani Gutta P: Regulation of cytokine mRNA expression in activated lymphocytes by human choriocarcinoma JAR cells. Cell Immunol 1996; 168:251-257.
24. King A, Loke YW: The inhibitory effect of human syncytiotrophoblast plasma membrane vesicles on in vitro lymphocyte proliferation is associated with reduced interleukin 2 receptor expression. Cell Immunol 1991; 138:165-174.
25. Bennett WA, Brackin MN, Long CA, Cowan BD: Comparison of immunosuppressive properties of hydatidiform mole decidua and trophoblast extracts. Am J Reprod Immunol 1996; 36:86-89.
26. Markert UR, Klemm A, Flossmann E, Werner W, Sperschneider H, Funfstück R: Renal transplantation at week 3 of pregnancy with acute rejection of the graft and development of a hydatidiform mole. Clin Nephrol 1998; 49:391-392.
27. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ: A family of cytokine-inducible inhibitors of signalling. Nature 1997; 387:917-921.
28. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387:921-924.
29. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T: Structure and function of a new STAT induced STAT inhibitor. Nature 1997; 387(6636):924-929.
30. Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman JW, Sedmak DD: Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998; 187:675-683.